Parkside Financial Bank & Trust’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $22K | Hold |
258
| – | – | ﹤0.01% | 1348 |
|
|
2026
Q1 | $17K | Buy |
258
+5
| +2% | +$318 | ﹤0.01% | 1370 |
|
|
2025
Q4 | $16.1K | Buy |
253
+38
| +18% | +$2.36K | ﹤0.01% | 1377 |
|
|
2025
Q3 | $11.8K | Sell |
215
-53
| -20% | -$2.18K | ﹤0.01% | 1458 |
|
|
2025
Q2 | $8.86K | Buy |
268
+53
| +25% | +$1.84K | ﹤0.01% | 1518 |
|
|
2025
Q1 | $8.64K | Buy |
+215
| New | +$9.88K | ﹤0.01% | 1456 |
|
|
2024
Q1 | – | Sell |
-22
| Closed | -$1.84K | – | 2045 |
|
|
2023
Q4 | $1.84K | Sell |
22
-260
| -92% | -$9.41K | ﹤0.01% | 1516 |
|
|
2023
Q3 | $8.31K | Buy |
282
+7
| +3% | +$233 | ﹤0.01% | 1182 |
|
|
2023
Q2 | $8.97K | Hold |
275
| – | – | ﹤0.01% | 1156 |
|
|
2023
Q1 | $9.68K | Hold |
275
| – | – | ﹤0.01% | 1119 |
|
|
2022
Q4 | $12.6K | Hold |
275
| – | – | ﹤0.01% | 985 |
|
|
2022
Q3 | $13K | Hold |
275
| – | – | ﹤0.01% | 916 |
|
|
2022
Q2 | $11K | Hold |
275
| – | – | ﹤0.01% | 964 |
|
|
2022
Q1 | $10K | Hold |
275
| – | – | ﹤0.01% | 1020 |
|
|
2021
Q4 | $13K | Hold |
275
| – | – | ﹤0.01% | 932 |
|
|
2021
Q3 | $10K | Buy |
275
+53
| +24% | +$1.56K | ﹤0.01% | 958 |
|
|
2021
Q2 | $4K | Hold |
222
| – | – | ﹤0.01% | 1302 |
|
|
2021
Q1 | $5K | Hold |
222
| – | – | ﹤0.01% | 1193 |
|
|
2020
Q4 | $5K | Buy |
222
+148
| +200% | +$2.71K | ﹤0.01% | 1098 |
|
|
2020
Q3 | $2K | Hold |
74
| – | – | ﹤0.01% | 1145 |
|
|
2020
Q2 | $2K | Hold |
74
| – | – | ﹤0.01% | 1149 |
|
|
2020
Q1 | $1K | Hold |
74
| – | – | ﹤0.01% | 1235 |
|
|
2019
Q4 | $1K | Hold |
74
| – | – | ﹤0.01% | 1355 |
|
|
2019
Q3 | $1K | Hold |
74
| – | – | ﹤0.01% | 1325 |
|
|
2019
Q2 | $1K | Buy |
+74
| New | +$714 | ﹤0.01% | 1343 |
|
|
2019
Q1 | – | Sell |
-76
| Closed | – | – | 1567 |
|
|
2018
Q4 | $0 | Buy |
+76
| New | +$558 | ﹤0.01% | 1475 |
|
|
2018
Q3 | – | Sell |
-44
| Closed | – | – | 1543 |
|
|
2018
Q2 | $0 | Sell |
44
-24
| -35% | -$200 | ﹤0.01% | 1542 |
|
|
2018
Q1 | $0 | Buy |
+68
| New | +$583 | ﹤0.01% | 1458 |
|
|
2017
Q4 | – | Sell |
-14
| Closed | – | – | 1387 |
|
|
2017
Q3 | $0 | Buy |
+14
| New | +$191 | ﹤0.01% | 1406 |
|
Other funds holding CYTK
ACA
Parkside Financial Bank & Trust's CYTK Position: Q2 2026 in Review
Parkside Financial Bank & Trust held its Cytokinetics (CYTK) position steady in Q2 2026 at 258 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #1348.
Parkside Financial Bank & Trust first reported a position in CYTK in Q3 2017 and has held it in 29 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.
- Parkside Financial Bank & Trust held 258 shares of Cytokinetics worth $22K as of Q2 2026.
- Parkside Financial Bank & Trust left its Cytokinetics share count unchanged in Q2 2026.
- Cytokinetics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1348 holding.
- Parkside Financial Bank & Trust first reported a position in Cytokinetics in Q3 2017 and has held it in 29 quarters since.
- 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.
Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.